Last10K.com

Biorestorative Therapies, Inc. (BRTX) SEC Filing 8-K Material Event for the period ending Friday, April 14, 2023

Biorestorative Therapies, Inc.

HISTORY TOOLS
CIK: 1505497 Ticker: BRTX

View differences made from one to another to evaluate Biorestorative Therapies, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Biorestorative Therapies, Inc..

Continue

Assess how Biorestorative Therapies, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Biorestorative Therapies, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2023 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 8-K Corporate News

Cover

Material Contracts, Statements, Certifications & more

Biorestorative Therapies, Inc. provided additional information to their SEC Filing as exhibits

Exhibit 1.1: Underwriting Agreement
Exhibit 5.1: Opinion Regarding Legality
Ticker: BRTX
CIK: 1505497
Form Type: 8-K Corporate News
Accession Number: 0001493152-23-012377
Submitted to the SEC: Fri Apr 14 2023 5:21:14 PM EST
Accepted by the SEC: Fri Apr 14 2023
Period: Friday, April 14, 2023
Industry: Health And Allied
Events:
  1. Financial Exhibit
  2. New Agreement

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/brtx/0001493152-23-012377.htm